Novavax
NVAX
#5818
Rank
S$1.40 B
Marketcap
S$8.64
Share price
-1.77%
Change (1 day)
-28.97%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): S$0.50 Billion

According to Novavax's latest financial reports the company's current earnings are S$1.02 Billion. In 2024 the company made an earning of -S$0.21 Billion, an increase over its 2023 earnings that were of -S$0.69 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.50 B-348.64%
2024 -S$0.21 Billion-70.39%
2023 -S$0.69 Billion-16.59%
2022 -S$0.83 Billion-62.58%
2021 -S$2.2 Billion320.54%
2020 -S$0.53 Billion234.22%
2019 -S$0.16 Billion-30.17%
2018 -S$0.23 Billion1.69%
2017 -S$0.23 Billion-36.44%
2016 -S$0.35 Billion70.4%
2015 -S$0.21 Billion89.27%
2014 -S$0.11 Billion59.83%
2013 -S$67.2 Million81.9%
2012 -S$36.95 Million50.33%
2011 -S$24.58 Million
2009 -S$48.5 Million8.8%
2008 -S$44.58 Million18.01%
2007 -S$37.78 Million18.33%
2006 -S$31.93 Million168.31%
2005 -S$11.9 Million-62.51%
2004 -S$31.74 Million52.4%
2003 -S$20.83 Million-28.21%
2002 -S$29.01 Million
2000 -S$16.54 Million177%
1999 -S$5.97 Million-11.54%
1998 -S$6.75 Million10.64%
1997 -S$6.1 Million-9.62%
1996 -S$6.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Agenus
AGEN
S$26.8 M-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-S$0.33 Billion-167.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.21 B-55.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-S$8.59 Million-101.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$16.98 B 3,390.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
S$15.37 B 3,060.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$21.30 B 4,278.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
-S$12.29 Million-102.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$12.09 B 2,386.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-S$0.34 Billion-168.33%๐Ÿ‡บ๐Ÿ‡ธ USA